Neoadjuvant therapy in resectable non-stage IV non-small cell lung cancer: real-world analysis

被引：0
|
作者：
Ay, L. [1 ,2 ]
Fabikan, H. [1 ]
Steiner, D. [3 ]
Illini, O. [1 ,2 ]
Krenbek, D. [4 ]
Klikovits, T. [5 ]
Lang-Stoeberl, A. [1 ]
Mueser, N. [1 ,6 ]
Kirchbacher, K. [1 ,6 ]
Funk, G. C. [1 ,6 ]
Watzka, S. [5 ]
Valipour, A. [1 ,2 ]
Hochmair, M. [1 ,2 ]
机构：
[1] Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria
[2] Klin Floridsdorf, Vienna Healthcare Grp, Dept Resp & Crit Care Med, Vienna, Austria
[3] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria
[4] Klin Floridsdorf, Vienna Healthcare Grp, Dept Pathol, Vienna, Austria
[5] Klin Floridsdorf, Vienna Healthcare Grp, Dept Thorac Surg, Vienna, Austria
[6] Klin Ottakring, Vienna Healthcare Grp, Dept Internal Med Pulmonol 2, Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2024年 / 136卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P25
引用
收藏
页码：S533 / S533
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
  • [22] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
  • [23] Real-world monitoring of hybrid dosing of pembrolizumab in stage IV non-small cell lung cancer in the Netherlands
    Dronkers, E.
    Van Geffen, E.
    Bekkers, C.
    Sobels, A.
    van Drie-Pierik, R.
    Eldering-Heldens, A.
    Zwaveling, J.
    Eijsink, J.
    Smit, H. J. M.
    Hilarius, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S73 - S73
  • [24] Neoadjuvant Chemoimmunotherapy (CIT) In Resectable Non-Small Cell Lung Cancer (NSCLC): Real-World Treatment Patterns and Surgical Outcomes
    Gibson, A. J.
    Dean, M. L.
    Litt, I.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S543 - S543
  • [25] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
  • [26] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [27] Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World
    Chen, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S579 - S580
  • [28] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [29] Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer
    Bao, Yi
    Gu, Chang
    Xie, Huikang
    Zhao, Shengnan
    Xie, Dong
    Chen, Chang
    Jiang, Gening
    Dai, Chenyang
    Zhu, Yuming
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [30] Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
    Hu, Yan
    Ren, Siying
    Yang, Lulu
    Tong, Zhongyi
    Wang, Ruoyao
    Han, Wei
    Zeng, Chao
    Li, Jina
    Xiao, Peng
    Wang, Li
    Yu, Fenglei
    Liu, Wenliang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345